Published in Br J Clin Pharmacol on November 01, 1984
The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis. Br J Clin Pharmacol (1991) 0.80
Amiodarone pharmacokinetics. Am Heart J (1983) 2.42
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation (1983) 1.57
Pancreatic venous sampling and arteriography in localizing insulinomas and gastrinomas: procedure and results in 55 cases. Radiology (1982) 1.37
Metabolism of flurazepam by the small intestine. Clin Pharmacol Ther (1977) 1.19
Rapid high-performance liquid chromatographic method for the measurement of amiodarone in blood plasma or serum at the concentrations attained during therapy. J Chromatogr (1980) 1.02
Methods of the assessment of the effect of drugs on liver blood flow in man. Br J Clin Pharmacol (1979) 0.95
Amiodarone distribution in human tissues after sudden death during Holter recording. Am J Cardiol (1983) 0.87
Bioavailability of amiodarone. Eur J Clin Pharmacol (1984) 0.86
Selective vein catheterization for hormone assay in endocrine tumours of the pancreas. Technique and results. Acta Radiol Diagn (Stockh) (1980) 0.85
Intestinal absorption, demethylation, and enterohepatic circulation of imipramine. Clin Pharmacol Ther (1976) 0.84
What is the best similarity measure for motion correction in fMRI time series? IEEE Trans Med Imaging (2002) 4.09
Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome. Cell (1991) 3.98
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A (2001) 3.86
The osmotic pressure of globin. Biochem J (1932) 3.69
Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging (2001) 3.25
Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg (1992) 2.76
Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan). Eur J Pharmacol (1967) 2.73
Three-dimensional multimodal brain warping using the demons algorithm and adaptive intensity corrections. IEEE Trans Med Imaging (2001) 2.58
During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg (1999) 2.37
Primary structure of dystrophin-related protein. Nature (1992) 2.09
Is the acetazolamide test valid for quantitative assessment of maximal cerebral autoregulatory vasodilation? An experimental study. Stroke (2000) 2.03
Molecular heterogeneity of the fragile X syndrome. Nucleic Acids Res (1991) 2.00
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol (2000) 1.95
A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol (1990) 1.86
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol (1998) 1.80
Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. N Engl J Med (1999) 1.75
Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg (2002) 1.74
Percutaneous gastrostomy with fluoroscopic guidance: single-center experience in 500 consecutive cancer patients. Radiology (1999) 1.70
Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg (1995) 1.64
Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. AJR Am J Roentgenol (2001) 1.61
Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend (1999) 1.60
Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 cases. Ann Oncol (2005) 1.59
Heterogeneous regional vascular responses to simulated transient hypovolemia in man. Intensive Care Med (1994) 1.58
Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures. Eur J Pharmacol (1968) 1.56
The importance of school and social activities in the transmission of influenza A(H1N1)v: England, April - June 2009. Euro Surveill (2009) 1.54
Comparison between conventional axillary block and a new approach at the midhumeral level. Anesth Analg (1997) 1.50
Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology (1996) 1.46
Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats. Cardiovasc Res (1999) 1.46
Complete remission seven years after treatment for metastatic malignant melanoma. Cancer (1996) 1.45
[Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience]. Gastroenterol Clin Biol (1999) 1.45
Genotype prediction in the fragile X syndrome. J Med Genet (1991) 1.45
Repeatability of transcranial Doppler measurements of arterial blood flow velocities in healthy subjects. Clin Sci (Lond) (1993) 1.40
Clearance of atrial natriuretic peptide in patients with cirrhosis. Role of liver failure. J Hepatol (1991) 1.39
[Transient arrhythmia disclosing major glycine poisoning during hysteroscopy]. Ann Fr Anesth Reanim (1995) 1.39
Oseltamivir adherence and side effects among children in three London schools affected by influenza A(H1N1)v, May 2009 - an internet-based cross-sectional survey. Euro Surveill (2009) 1.37
Pancreatic venous sampling and arteriography in localizing insulinomas and gastrinomas: procedure and results in 55 cases. Radiology (1982) 1.37
Hepatic hemobilia of traumatic or iatrogenic origin: recent advances in diagnosis and therapy, review of the literature from 1976 to 1981. World J Surg (1984) 1.34
Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients. Br J Clin Pharmacol (1984) 1.30
A YAC contig across the fragile X site defines the region of fragility. Nucleic Acids Res (1991) 1.29
The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br J Clin Pharmacol (1985) 1.28
Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology (1994) 1.26
Endovascular management of bleeding iliac artery pseudoaneurysms complicating radiation therapy for pelvic malignancies. AJR Am J Roentgenol (1998) 1.24
Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer (1993) 1.23
Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug. J Pharmacol Exp Ther (1969) 1.22
Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology (1993) 1.20
Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J Med Genet (2009) 1.19
Gianturco expandable metallic biliary stents: results of a European clinical trial. Radiology (1989) 1.19
Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. Am J Clin Pathol (1997) 1.18
Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol (1999) 1.16
Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther (1995) 1.15
Studies on the nature of the bronchial -adrenoreceptors. Eur J Pharmacol (1971) 1.14
Liver abscess formation after local treatment of liver tumors. Hepatology (1996) 1.13
MRI volume of the amygdala: a reliable method allowing separation from the hippocampal formation. Psychiatry Res (1999) 1.13
Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol (2002) 1.12
Preliminary assessment of flutiorex, a new anorectic drug, in man. Br J Clin Pharmacol (1976) 1.09
Pharmacological postconditioning with the phytoestrogen genistein. J Mol Cell Cardiol (2006) 1.07
Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology (1993) 1.06
[Primary malignant melanoma of the small intestine]. Gastroenterol Clin Biol (1992) 1.06
Influence of sex on drug kinetics in man. Clin Pharmacokinet (1977) 1.06
Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med (1996) 1.05
Alkalinization of epidural 0.5% bupivacaine for cesarean section. Reg Anesth (1991) 1.05
Radio-frequency tissue ablation of the liver: effects of vascular occlusion on lesion diameter and biliary and portal damages in a pig model. Eur Radiol (2001) 1.05
Self-expanding metallic stents as palliative treatment of malignant gastroduodenal stenosis. AJR Am J Roentgenol (1997) 1.04
Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system. Eur J Pharmacol (1968) 1.03
Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision making. Radiology (1992) 1.03
Hemobilia caused by a pseudoaneurysm of the hepatic artery diagnosed by EUS. Gastrointest Endosc (1999) 1.03
Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer. J Cardiovasc Pharmacol (1987) 1.02
Arterioureteral fistula after extended resection of pelvic tumors: report of three cases and review of the literature. Ann Vasc Surg (1992) 1.02
Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. Radiology (1992) 1.02
Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. J Nucl Med (1996) 1.02
A deletion in the bone morphogenetic protein 15 gene causes sterility and increased prolificacy in Rasa Aragonesa sheep. Anim Genet (2008) 1.01
Diseases and drug protein binding. Clin Pharmacokinet (1978) 1.01
Linear order of new and established DNA markers around the fragile site at Xq27.3. Genomics (1991) 1.00
Preoperative assessment of resectability of hepatic metastases from colonic carcinoma: CT portography vs sonography and dynamic CT. AJR Am J Roentgenol (1992) 1.00
[Therapeutic embolization for traumatic renal haemorrhage. 11 cases (author's transl)]. Nouv Presse Med (1980) 1.00
Odorous urine in man after asparagus. Br J Clin Pharmacol (1989) 1.00
Fotemustine in the treatment of brain primary tumors and metastases. Cancer Invest (1994) 0.99
Phase II study of fotemustine in recurrent supratentorial malignant gliomas. Eur J Cancer (1991) 0.98
First birth of an animal from an extinct subspecies (Capra pyrenaica pyrenaica) by cloning. Theriogenology (2009) 0.98
The aryl hydrocarbon receptor and its xenobiotic ligands: a fundamental trigger for cardiovascular diseases. Nutr Metab Cardiovasc Dis (2003) 0.97
Preoperative selective portal vein embolizations are an effective means of extending the indications of major hepatectomy in the normal and injured liver. Hepatogastroenterology (1998) 0.97
Ultrasonic imaging of the coronary arteries in open-chest humans: evaluation of coronary atherosclerotic lesions during cardiac surgery. Circulation (1982) 0.96
Captopril and hypertension development in the SHR. Clin Exp Hypertens (1980) 0.96
Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol (1983) 0.96
Comparative diffusion study of two nitrosoureas: carmustine and fotemustine in normal rat brain, human and rat brain biopsies. Chemotherapy (1991) 0.96
Potassium channel openers dilate large epicardial coronary arteries in conscious dogs by an indirect, endothelium-dependent mechanism. J Pharmacol Exp Ther (1992) 0.95
Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration. Gene Ther (2006) 0.95
The association between clubfoot and developmental dysplasia of the hip. J Bone Joint Surg Br (2010) 0.95
Preoperative segmental localization of hepatic metastases: utility of three-dimensional CT during arterial portography. Radiology (1991) 0.94
Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia. FASEB J (2005) 0.94
Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol (2001) 0.94
Fluospheres for cardiovascular phenotyping genetically modified mice. J Cardiovasc Pharmacol (2000) 0.93